Replies to post #124416 on Avid Bioservices Inc (CDMO)

[BioChica]

I seen one patient discontinued Bavituximab treatment in the ASCO Abstract's pasted info pasted by Jake17. Just wondering if she did not continue treatment, would she be replaced by another? Waht do they do in this case?

Category:
Breast Cancer - HER2/ER

Meeting:
2013 ASCO Annual Meeting

Abstract No:
567

Citation:
J Clin Oncol 31, 2013 (suppl; abstr 567)

Bavi related toxicities include grade2/3 infusion related reactions in 2 pts (1 discontinued Bavi).